Intrado Completes Divestiture of Health Advocate

ISLANDIA, N.Y., June 22, 2021 (GLOBE NEWSWIRE) -- Intrado Corporation (“Intrado” or the “Company”), a global leader in technology-enabled services, today announced it has completed the previously announced sale of its Health Advocate business to Teleperformance. The sale of this business will allow Intrado to further focus on its remaining cloud-based technology and next generation solutions.

The purchase price was approximately $690 million. The net proceeds of the sale which reflect, among other things, the netting of taxes, fees, and expenses relating to the sale, are approximately $591 million. The Company intends to use approximately $350 million of the net proceeds to repay a portion of its outstanding term loans and approximately $100 million to repurchase its 8.50% Senior Notes due 2025 via an asset sale offer. The Company expects to use the remaining net proceeds to reinvest in the business.

About Intrado

Intrado Corporation is an innovative, cloud-based, global technology partner to clients around the world. Our solutions connect people and organizations at the right time and in the right ways, making those mission-critical connections more relevant, engaging, and actionable - turning Information to Insight.

Intrado has sales and/or operations in the United States, Canada, Europe, the Middle East, Asia Pacific, Latin America, and South America. Intrado is controlled by affiliates of certain funds managed by Apollo Global Management, Inc. (NYSE: APO). For more information, please call 1-800-841-9000 or visit www.intrado.com.

Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties. Forward-looking statements include any statements that address future results or occurrences. In some cases you can identify forward-looking statements by terminology such as “may,” “might,” “will,” should,” “could,” or the negatives thereof. Generally, the words “anticipate,” “believe,” “continue,” “expect,” “intend,” “estimate,” “project,” “plan,” and similar expressions identify forward-looking statements. In particular, statements about our expectations, beliefs, plans, objectives, assumptions of future events or performance contained elsewhere in this press release are forward-looking statements. These forward-looking statements include statements that are not historical facts, including statements concerning our possible or assumed future actions and business strategies. We have based these forward-looking statements on our current expectations, assumptions, estimates, and projections. While we believe these expectations, assumptions, estimates, and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks, uncertainties and other factors, many of which are outside of our control, which could cause our actual results, performance, or achievements to differ materially from any results, performance, or achievements expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. We disclaim any obligation to update any such factors or to announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events, or developments. Statements in this press release are made as of the date hereof. New factors emerge from time to time that could cause our actual results to differ, and it is not possible to predict all such factors.

Contact

Dave Pleiss
Investor and Public Relations
[email protected]
402-716-6578

You May Also Be Interested In

• SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024
• Brandywine Realty Trust to Redeem All Outstanding 4.10% Guaranteed Notes due 2024
• Bolo Program Puts $1 Million on the Table, Unveils Unprecedented Incentive for Community Members to Be on the Lookout for Canada’s Most Wanted Fugitives